Chng a ‘rising star’ in bacterial membrane lipid research

Researcher wins ASBMB's Walter A. Shaw Young Investigator Award
Courtney Chandler
April 1, 2019

Shu-Sin Chng, a professor in the department of chemistry at the National University of Singapore, has been awarded the American Society for Biochemistry and Molecular Biology’s 2019 Walter A. Shaw Young Investigator Award. The award recognizes Chng’s work on outer membrane biogenesis in Gram-negative bacteria and mycobacteria.

In her letter supporting Chng’s nomination for the award, Tracy Palmer of Newcastle University wrote that his research has made “an outstanding contribution to our understanding of bacterial lipid trafficking” and that Chng “has already cemented himself as a world leader in his field.”

Shu-Sin Chng “I am extremely excited and honored to receive the Walter Shaw Young Investigator Award in Lipid Research. I am deeply indebted to my mentors Daniel Kahne and Jonathan Beckwith for providing exceptional training, friendship and support throughout my career. I am also very grateful to my postdocs and students past and present for their commitment, patience and hard work — this success also belongs to them!” — Shu-Sin Chng

The outer membrane of Gram-negative bacteria has a unique composition compared to the inner membrane. While mechanisms for outer membrane protein and glycolipid transport and assembly have been well defined, how glycerophospholipids are transported to and from the outer membrane was largely unknown. Chng has investigated how phospholipids are transported by the OmpC-Mla system, which is important for the maintenance of outer membrane lipid asymmetry in Escherichia coli. The Mla system had been described previously, but Chng identified a new component OmpC, defined the biochemical mechanisms of this system and demonstrated that it did in fact transport lipids. The Chng lab also reported that the Tol-Pal complex, first defined over 50 years ago, is involved in phospholipid transport. In what Palmer described as a “profound discovery,” Chng’s group demonstrated that this complex is important for the retrograde transport of phospholipids from the outer to inner membrane and is thus required for outer membrane lipid homeostasis in Gram-negative bacteria.

Chng also investigates mycobacteria, which have evolved an outer membrane rich in mycolic acids. Mycobacteria are notoriously hard to work with, yet Chng was able to describe how mycolic acids are flipped by a protein called MmpL3, as well as how MmpL3 is the direct target for small molecule inhibitors. Mycolic acid synthesis is an important pathway for targeted antibiotic therapies. Thus, Chng’s research on lipid transport in mycobacteria could lay the groundwork for improved therapies against mycobacterial infection.

Jean-Francois Collet of the Université catholique de Louvain nominated Chng for the award. “The importance of his work is greatly amplified given that the bacterial (outer membrane) is a prime target for the development of novel antibiotics, especially in the context of combat against multidrug resistant ‘superbugs,’” Collet wrote in his nomination letter.

Hiroshi Nikaido, of the University of California, Berkeley, wrote in support of the nomination that he “was struck by both the range of Dr. Chng’s work as well as the creativity and originality in his studies,” while Stephen Trent of the University of Georgia called Chng “a rising star.”

Chng received his Ph.D. in chemistry at Harvard University in 2010, and he remained at Harvard as a postdoctoral fellow. In 2011, he joined the department of chemistry at the National University of Singapore. He is also a visiting professor at the Singapore Center on Environmental Life Sciences and Engineering.

Chng will receive his award during the ASBMB annual meeting at the Experimental Biology 2019 conference in Orlando, where he will deliver an award lecture titled “Bacterial lipid trafficking and outer membrane homeostasis” at 1:45 p.m. April 8 in Valencia Ballroom A at the Orange County Convention Center.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Courtney Chandler

Courtney Chandler is a biochemist and microbiologist in Baltimore, Md., and a careers columnist for ASBMB Today.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

‘With advances in mass spectrometry, we can explore terra incognita’

‘With advances in mass spectrometry, we can explore terra incognita’

Sept. 29, 2022

A conversation with Molecular & Cellular Proteomics associate editor Albert Heck, a researcher at Utrecht University.

In memoriam: Clark Bublitz
In Memoriam

In memoriam: Clark Bublitz

Sept. 26, 2022

He was a metabolic enzymologist and a member of the American Society for Biochemistry and Molecular Biology since 1963.

Understanding protein dynamics to design better drugs
Research Spotlight

Understanding protein dynamics to design better drugs

Sept. 21, 2022

C. Denise Okafor is an assistant professor of biochemistry and molecular biology at Penn State and recipient of an NSF CAREER award.

Computation is the new experiment
Annual Meeting

Computation is the new experiment

Sept. 20, 2022

This symposium, Artificial Intelligence and Machine Learning in Structural Biology, Drug Design and Systems Biology. will be part of #DiscoverBMB 2023 in March.

Kuriyan to take over as dean;  Johnson wins Pew scholarship
Member News

Kuriyan to take over as dean; Johnson wins Pew scholarship

Sept. 19, 2022

Awards, promotions, milestones and more. Find out what's going on in the lives of ASBMB members.

'Keep developing your expertise'

'Keep developing your expertise'

Sept. 16, 2022

Anand Balakrishnan is a biochemist at Enanta Pharmaceuticals. He leads a team that has worked on respiratory syncytial virus, SARS-CoV-2 and hepatitis B virus.